One of the most important things on the mind of any entrepreneur in the late-stage developing their business is exit strategies. Exiting can be a very risky process and it is hard to know sometimes whether or not your company is ready for it. If so, how can you be sure you are following through with the best deal? Matt Megaro has extensive experience in starting and developing biotechnology and medical devices ventures and shared his thoughts with us on current trends in life science exits.
